Harald Hefter

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 27

Top Topics

Botulinum Toxin

Mesenchymal Stem Cells

Chronic Kidney Disease

Top Venues

Journal of neurology

Medicina (Kaunas, Lithuania)

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Beyza Ürer, Raphaela Brauns, Dietmar Rosenthal, Philipp Albrecht, Sara Samadzadeh
Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study. Toxins 15 (7) (2023)
Harald Hefter, Dietmar Rosenthal, Sara Samadzadeh
"Pseudo"-Secondary Treatment Failure Explained via Disease Progression and Effective Botulinum Toxin Therapy: A Pilot Simulation Study. Toxins 15 (10) (2023)
Harald Hefter, Sara Samadzadeh
Exploring the Interplay between the Clinical and Presumed Effect of Botulinum Injections for Cervical Dystonia: A Pilot Study. Toxins 15 (10) (2023)
Harald Hefter, Theodor S Kruschel, Max Novak, Dietmar Rosenthal, Tom Luedde, Sven G Meuth, Philipp Albrecht, Christian J Hartmann, Sara Samadzadeh
Differences in the Time Course of Recovery from Brain and Liver Dysfunction in Conventional Long-Term Treatment of Wilson Disease. Journal of clinical medicine 12 (14) (2023)
Harald Hefter, Raphaela Brauns, Beyza Ürer, Dietmar Rosenthal, Philipp Albrecht, Sara Samadzadeh
No Secondary Treatment Failure during Incobotulinumtoxin-A Long-Term Treatment Demonstrated by the Drawing of Disease Severity. Toxins 15 (7) (2023)
Max Arslan, Max Novak, Dietmar Rosenthal, Christian J Hartmann, Philipp Albrecht, Sara Samadzadeh, Harald Hefter
Cholinesterase Deficiency Syndrome-A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson's Disease. Biomolecules 12 (10) (2022)
Sara Samadzadeh, Harald Hefter, Osman Tezayak, Dietmar Rosenthal
Analysis of Running in Wilson's Disease. Sports (Basel, Switzerland) 10 (1) (2022)
Harald Hefter, Beyza Ürer, Raphaela Brauns, Dietmar Rosenthal, Sven G Meuth, John-Ih Lee, Philipp Albrecht, Sara Samadzadeh
The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia. Journal of neurology 269 (11) (2022)
Harald Hefter, Beyza Ürer, Raphaela Brauns, Dietmar Rosenthal, Sven G Meuth, John-Ih Lee, Philipp Albrecht, Sara Samadzadeh
Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure. Toxins 14 (1) (2022)
Harald Hefter, Sara Samadzadeh
The Necessity of a Locally Active Antidote in the Clinical Practice of Botulinum Neurotoxin Therapy: Short Communication. Medicina (Kaunas, Lithuania) 58 (7) (2022)
Harald Hefter, Dietmar Rosenthal, Alexander Jansen, Raphaela Brauns, Beyza Ürer, Hans Bigalke, Hans-Peter Hartung, Sven G Meuth, John-Ih Lee, Philipp Albrecht, Sara Samadzadeh
Significantly lower antigenicity of incobotulinumtoxin than abo- or onabotulinumtoxin. Journal of neurology (2022)
Sara Samadzadeh, Theodor Kruschel, Max Novak, Michael Kallenbach, Harald Hefter
Different Response Behavior to Therapeutic Approaches in Homozygotic Wilson's Disease Twins with Clinical Phenotypic Variability: Case Report and Literature Review. Genes 13 (7) (2022)
Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Dietmar Rosenthal, Sara Samadzadeh
The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot Study. Medicina (Kaunas, Lithuania) 58 (1) (2022)
Harald Hefter, Sara Samadzadeh, Dietmar Rosenthal, Osman Tezayak
Analysis of Single-Leg Hopping in Long-Term Treated Patients with Neurological Wilson's Disease: A Controlled Pilot Study. Medicina (Kaunas, Lithuania) 58 (2) (2022)
Harald Hefter, Werner Nickels, Sara Samadzadeh, Dietmar Rosenthal
Comparing soleus injections and gastrocnemius injections of botulinum toxin for treating adult spastic foot drop: a monocentric observational study. The Journal of international medical research 49 (3) (2021)
Sara Samadzadeh, Harald Hefter, Osman Tezayak, Dietmar Rosenthal
Mildly Impaired Foot Control in Long-Term Treated Patients with Wilson's Disease. Journal of functional morphology and kinesiology 7 (1) (2021)
Sara Samadzadeh, Raphaela Brauns, Dietmar Rosenthal, Harald Hefter
The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany. Toxins 13 (2) (2021)
Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Dietmar Rosenthal, Sara Samadzadeh
The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia. Toxins 13 (7) (2021)
Harald Hefter, Sara Samadzadeh
Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson's Disease: Six Cases and Literature Review. Toxins 13 (4) (2021)
Harald Hefter, Judith Beek, Dietmar Rosenthal, Sara Samadzadeh
Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report. Toxins 13 (6) (2021)
Harald Hefter, Werner Nickels, Dietmar Rosenthal, Sara Samadzadeh, Philipp Albrecht
Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop. Toxins 13 (7) (2021)
Sara Samadzadeh, Raphaela Brauns, Harald Hefter
The Extreme Ends of the Treatment Response Spectrum to Botulinum Toxin in Cervical Dystonia. Toxins 13 (1) (2020)
Harald Hefter, Sara Samadzazeh, Dietmar Rosenthal
The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia. Journal of neurology 268 (1) (2020)
Sara Samadzadeh, Beyza Ürer, Raphaela Brauns, Dietmar Rosenthal, John-Ih Lee, Philipp Albrecht, Harald Hefter
Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and Literature. Toxins 12 (8) (2020)
Harald Hefter, Sara Samadzadeh, Marek Moll
Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA. Toxins 12 (11) (2020)
Harald Hefter, Raphaela Brauns, Beyza Ürer, Dietmar Rosenthal, Philipp Albrecht
Effective long-term treatment with incobotulinumtoxin (Xeomin®) without neutralizing antibody induction: a monocentric, cross-sectional study. Journal of neurology 267 (5) (2020)
Harald Hefter, Dietmar Rosenthal, Hans Bigalke, Marek Moll
Clinical relevance of neutralizing antibodies in botulinum toxin long-term treated still-responding patients with cervical dystonia. Therapeutic advances in neurological disorders 12 (2019)